4CPS-030 Evaluation of pharmacist-led cardiovascular services within primary care, provided by cardiovascular pharmacists

• Published in: European journal of hospital pharmacy. Science and practice Vol. 25; no. Suppl 1; p. A55
• Main Authors: Koch, K, Meddings, C, Collings, V, Bidad, N
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 01.03.2018; BMJ Group
• Subjects: Blood pressure; Drug stores; Health risk assessment; Hypertension; Pharmacists; Primary care; Section 4: Clinical pharmacy services
• DOI: 10.1136/ejhpharm-2018-eahpconf.121
• ISSN: 2047-9956

BackgroundThere is a limited amount of evidence demonstrating the benefit of pharmacy-led community services managing cardiovascular diseases. With an ever increasing demand on hospitals and a focus on preventing admission, the cardiovascular pharmacy team at a hospital is delivering both virtual clinics and pharmacist-led hypertension and lipid clinics with an overall aim of reducing cardiovascular disease risk factors for patients within primary care.PurposeThe aim of this report was to identify and evaluate the pharmacist-led cardiovascular services provided within primary care from June 2016 (when the new services were started) to July 2017.Material and methodsRetrospective data for all patients seen within the pharmacist-led clinics and hypertension virtual clinics and all returned surveys were included in this service evaluation.ResultsA total of 65 patients from the hypertension virtual clinic were reviewed. There were 108 pharmacists’ interventions made and 51 patients were followed-up after 6 months. Blood pressure was recorded at 6 months for 34 patients and a mean systolic blood pressure decline of −18 (±18.0) mmHg was observed. There were 26 patients who had a systolic blood pressure >160 mm/Hg compared with three patients after 6 months. A total of 17 patients have been seen in the pharmacist-led clinics; of which six patients have had follow-up recordings. A mean systolic blood pressure decline of −23 (±2.0) mmHg was achieved for three patients and a mean non-HDL decline of −1.61 (±0.69) mmol/l was achieved in three patients. The satisfaction of service users was stated as high in the returned surveys.ConclusionDue to small numbers of patients, statistical significance could not be calculated. However, the available data shows an overall positive trend in patient outcomes and high satisfaction rating.References and/or AcknowledgementsI want to thank the staff of University College London and Guy’s and St. Thomas’ NHS Foundation Trust for their help, support and collaboration.No conflict of interest